A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers

NCT01640990 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Injury, Acute

Interventions

DRUG: Saline
DRUG: GW328267X (total dose of 12mcg)
DRUG: GW328267X (total dose of 40mcg)

Sponsor

GlaxoSmithKline